TipRanks
Go Ultimate55% OFF

Clinigence Holdings (NUTX) Stock Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

NUTX Analyst Ratings

Strong Buy
5Ratings
5Buy0Hold0Sell
Based on 5 analysts giving stock ratings to Clinigence Holdings in the past 3 months

NUTX Stock 12 Month Forecast

$295.40▲(47.59% Upside)
Based on 5 Wall Street analysts offering 12 month price targets for Clinigence Holdings in the last 3 months. The average price target is $295.40 with a high forecast of $336.00 and a low forecast of $200.00. The average price target represents a 47.59% change from the last price of $200.15.
Highest Price Target$336.00Average Price Target$295.40Lowest Price Target$200.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for NUTX
Price TargetFollowArticle
Ladenburg Thalmann & Co.$336buy67.87%UpsideInitiated10/26/26
Freedom Capital Markets$280→$306buy52.89%UpsideReiterated09/25/26
B. Riley Securities$290→$325buy62.38%UpsideReiterated09/04/26
Lake Street$310buy54.88%UpsideReiterated08/13/26
Maxim Group$175→$200buy-0.07%DownsideAssigned08/10/26
Benchmark Co.$300buy49.89%UpsideAssigned03/10/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AORTArtivion
MDWDMediwound
IMUXImmunic
RZLTRezolute
DFTXDefinium Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Clinigence Holdings

3 Months
Anthony Vendetti
Anthony VendettiMaxim Group
Success Rate7/10 ratings generated profit
70%
Average Return
+21.90%

Copying Anthony Vendetti's trades and holding each position for 3 Months would result in 70.00% of your transactions generating a profit, with an average return of +21.90% per trade.

1 Year
Anthony Vendetti
Anthony VendettiMaxim Group
Success Rate9/10 ratings generated profit
90%
Average Return
+86.77%

Copying Anthony Vendetti's trades and holding each position for 1 Year would result in 90.00% of your transactions generating a profit, with an average return of +86.77% per trade.

2 Years
Anthony Vendetti
Anthony VendettiMaxim Group
Success Rate10/10 ratings generated profit
100%
Average Return
+194.42%

Copying Anthony Vendetti's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +194.42% per trade.

NUTX Analyst Recommendation Trends

02468Oct 25Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26
Monthly rating counts for NUTX
RatingMay 26Jun 26Jul 26Aug 26Sep 26
Strong Buy22323
Buy11122
Hold00000
Sell00000
Strong Sell00000
total33445

In the current month, NUTX has received 5 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. NUTX average Analyst price target in the past 3 months is 295.40.

NUTX Financial Forecast

$0$2.5$5$7.5$10Q4 2025Q2 2026Q3 2026
High$6.56
Consensus$5.54
Low$4.71

NUTX Earnings Forecast

Next quarter’s earnings estimate for NUTX is $5.54 with a range of $4.71 to $6.56. The previous quarter’s EPS was $9.38. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

$151.7M$180.7M$209.7M$238.8M$267.8MQ4 2025Q2 2026Q3 2026
High$217M
Consensus$215M
Low$211M

NUTX Sales Forecast

Next quarter’s sales forecast for NUTX is $214.82M with a range of $211.00M to $216.90M. The previous quarter’s sales results were $210.75M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

NUTX Stock Forecast FAQ

What is NUTX’s average 12-month price target, according to analysts?
Based on analyst ratings, Clinigence Holdings’s 12-month average price target is $295.40.
What is NUTX’s upside potential, based on the analysts’ average price target?
Clinigence Holdings has 47.59% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is NUTX a Buy, Sell or Hold?
Clinigence Holdings has a consensus rating of Strong Buy which is based on 5 buy ratings, 0 hold ratings and 0 sell ratings.
What is Clinigence Holdings’s price target?
The average price target for Clinigence Holdings is $295.40. This is based on 5 12-month price targets, issued in the past 3 months. The highest analyst price target is $336.00, the lowest forecast is $200.00. The average price target represents a 47.59% increase from the current price of $200.15.
What do analysts say about Clinigence Holdings?
Clinigence Holdings’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Street analysts.
How can I buy shares of NUTX?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.